Skip to main content
Signal8

Aslan Fred

SEC insider (Form 3/4/5 filer). CIK 0001909362. Chief Executive Officer at Artiva Biotherapeutics, Inc. (ARTV). 24 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in SAN DIEGO, CA.

Companies Aslan Fred has filed insider reports for

  • Artiva Biotherapeutics, Inc. (ARTV): Director, Officer, Chief Executive Officer
Aslan Fred profile photo

Aslan Fred

CIK: 0001909362

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (20.8%)

Compensation grants

Other (G, F, J, C, D, …)10 (41.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Artiva Biotherapeutics, Inc. logo
ARTV

Artiva Biotherapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (24 total)

  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Oct 6, 2026
    Sale
    Direct
    23.5K shares at avg. $7.20$169K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Oct 5, 2026
    Sale
    Direct
    61.7K shares at avg. $6.84$422K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 15, 2026
    Award
    Direct
    110K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 10, 2026
    Award
    Direct
    45K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 8, 2026
    Sale
    Direct
    23.4K shares at avg. $10.92$256K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 3, 2026
    Sale
    Direct
    61.9K shares at avg. $11.16$690K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    May 19, 2026
    Sale
    Direct
    27.1K shares at avg. $9.01$244K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Feb 15, 2026
    Tax Payment
    Direct
    14.6K shares at avg. $4.00$58K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Feb 15, 2026
    Award
    Direct
    366.9K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Dec 15, 2025
    Sale
    Direct
    3.2K shares at avg. $6.00$19K

1-10 of 24